| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
CAL-101 is a selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor used in cancer therapy. It interferes with the PI3Kδ pathway, inhibiting cell proliferation and promoting apoptosis. | ||||||
Syk Inhibitor IV, BAY 61-3606 HCl | 732983-37-8 | sc-202351 | 2 mg | $327.00 | 25 | |
BAY 61-3606 is a Syk (spleen tyrosine kinase) inhibitor that may indirectly impact E2A function by affecting downstream signaling pathways. | ||||||
ABT 263 | 923564-51-6 | sc-207241 | 5 mg | $245.00 | 16 | |
ABT 263 inhibits Bcl-2 family proteins, leading to disruption of mitochondrial pathways and apoptosis. It indirectly affects E2A function in B cell survival. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | $255.00 | ||
Acalabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that can affect B cell receptor signaling and indirectly influence E2A-mediated transcription. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib covalently binds to BTK and inhibits its activity, leading to decreased B cell receptor signaling and potential effects on E2A-driven processes. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a multi-kinase inhibitor that targets Src family kinases and BCR-ABL, impacting B cell receptor signaling and potentially E2A-associated functions. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide modulates the immune system and affects cytokine signaling, potentially influencing E2A-driven processes in immune cell differentiation. | ||||||
Tirabrutinib | 1351636-18-4 | sc-507435 | 10 mg | $138.00 | ||
ONO-4059 is a BTK inhibitor that can disrupt B cell receptor signaling, influencing downstream events involving E2A-mediated transcription. | ||||||
IPI 145 | 1201438-56-3 | sc-488318 | 5 mg | $317.00 | ||
Duvelisib inhibits both PI3Kδ and PI3Kγ, potentially impacting B cell signaling pathways and E2A-associated processes. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | $207.00 $515.00 | 6 | |
TG101348 inhibits JAK2 and other JAK family members, potentially affecting cytokine signaling and E2A-related functions in hematopoiesis. | ||||||